Stock PLSI PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Phoenix Life Sciences International Limited

Equities

PLSI

US71910Q1022

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ArCare Holdings Sdn Bhd entered into letter of intent to acquire Phoenix Life Sciences International Limited.
CI
PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Non-Reliance on Previous Financials, Audits or Interim Review, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Phoenix Life Sciences International Limited cancelled the transaction announced on April 30, 2019
CI
Phoenix Life Sciences International Limited Reports Earnings Results for the Full Year Ended February 28, 2019
CI
Phoenix Life Sciences International Limited Announces Management Changes
CI
Phoenix Life Sciences International Limited Announces Resignation of Michael Gobel from His Role as Director
CI
Phoenix Life Sciences International Limited Announces Management Changes
CI
Phoenix Life Sciences International Limited Announces Management Changes
CI
Phoenix Life Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License
GL
Phoenix Life Sciences International Limited Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License
CI
Phoenix Life Sciences International Announces Presentation at MjMicro Cap Conference in Preparation to Uplist to the OTCQB Market
GL
Phoenix Life Sciences International Limited Names Maturine Carlot-Tary as Director of Health and Nutrition
CI
Phoenix Life Announces $40 Million Capital Raise in Conjunction with TABOR Family Office Conference
GL
Phoenix Life Sciences International Limited announced that it expects to receive $40 million in funding
CI
Phoenix Life Announces Annual Financial Report Filings for 2017 and 2018
GL
Phoenix Life Sciences International Limited Appoints John Taleo as Global Head of Security
CI
Phoenix Life Sciences International Announces Giving Pledge Commitment and Launch of The Global Health Initiative with Kylie OBrien Ph.D.
GL
Phoenix Life Sciences International Limited announced that it has received $0.879685 million in funding
CI
Phoenix Life Sciences International Appoints Tekon Timothy Tumukon as Company's Head of Biosecurity Services
GL
Phoenix Life Sciences International Limited Appoints Tekon Timothy Tumukon as Head of Biosecurity Services
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLSI Stock
  4. News Phoenix Life Sciences International Limited